MALDI imaging of post‐mortem human spinal cord in amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is a devastating, rapidly progressing disease of the central nervous system that is characterized by motor neuron degeneration in the brainstem and the spinal cord. Matrix‐assisted laser desorption/ionization (MALDI) imaging mass spectrometry is an emerging powerful technique that allows for spatially resolved, comprehensive, and specific characterization of molecular species in situ. In this study, we report for the first time the MALDI imaging‐based spatial protein profiling and relative quantification of post‐mortem human spinal cord samples obtained from ALS patients and controls. In normal spinal cord, protein distribution patterns were well in line with histological features. For example, thymosin beta 4, ubiquitin, histone proteins, acyl‐CoA‐binding protein, and macrophage inhibitory factor were predominantly localized to the gray matter. Furthermore, unsupervised statistics revealed a significant reduction of two protein species in ALS gray matter. One of these proteins (m/z 8451) corresponds to an endogenous truncated form of ubiquitin (Ubc 1–76), with both C‐terminal glycine residues removed (Ubc‐T/Ubc 1–74). This region‐specific ubiquitin processing suggests a disease‐related change in protease activity. These results highlight the importance of MALDI mass spectrometry as a versatile approach to elucidate molecular mechanisms of neurodegenerative diseases.

[1]  R. Cooks,et al.  Desorption electrospray ionization imaging mass spectrometry of lipids in rat spinal cord , 2010, Journal of the American Society for Mass Spectrometry.

[2]  E. Petricoin,et al.  Clinical Proteomics: From Biomarker Discovery and Cell Signaling Profiles to Individualized Personal Therapy , 2005, Bioscience reports.

[3]  Richard M Caprioli,et al.  A Novel Histology-directed Strategy for MALDI-MS Tissue Profiling That Improves Throughput and Cellular Specificity in Human Breast Cancer* , 2006, Molecular & Cellular Proteomics.

[4]  M. Setou,et al.  Spatiotemporal alteration of phospholipids and prostaglandins in a rat model of spinal cord injury , 2012, Analytical and Bioanalytical Chemistry.

[5]  A. Chiò Risk factors in the early diagnosis of ALS: European epidemiological studies , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[6]  R. Caprioli,et al.  Identification of proteins directly from tissue: in situ tryptic digestions coupled with imaging mass spectrometry. , 2007, Journal of mass spectrometry : JMS.

[7]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  N. Calcutt,et al.  Considerations for quantification of lipids in nerve tissue using matrix-assisted laser desorption/ionization mass spectrometric imaging. , 2011, Rapid communications in mass spectrometry : RCM.

[9]  K. Markides,et al.  Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography‐Fourier transform ion cyclotron resonance mass spectrometry , 2004, Proteomics.

[10]  L. Ungar,et al.  Identification of potential CSF biomarkers in ALS , 2006, Neurology.

[11]  L. Petrucelli,et al.  Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system , 2004, Annals of medicine.

[12]  M. Karas,et al.  Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. , 1988, Analytical chemistry.

[13]  F. Bertucci,et al.  Protein Profiling of Human Breast Tumor Cells Identifies Novel Biomarkers Associated with Molecular Subtypes*S , 2008, Molecular & Cellular Proteomics.

[14]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[15]  R. Caprioli,et al.  MALDI Imaging Mass Spectrometry – Painting Molecular Pictures , 2010, Molecular oncology.

[16]  M. Stoeckli,et al.  Automated mass spectrometry imaging with a matrix-assisted laser desorption ionization time-of-flight instrument , 1999, Journal of the American Society for Mass Spectrometry.

[17]  Richard M Caprioli,et al.  Protein signatures for survival and recurrence in metastatic melanoma. , 2011, Journal of proteomics.

[18]  H J Bennett,et al.  How common is common? , 1991, Southern medical journal.

[19]  Michelle L. Reyzer,et al.  MALDI imaging mass spectrometry: molecular snapshots of biochemical systems , 2007, Nature Methods.

[20]  Shyr Yu,et al.  A novel comprehensive wave-form MS data processing method , 2009, Bioinform..

[21]  J. Bergquist,et al.  MALDI mass spectrometry based molecular phenotyping of CNS glial cells for prediction in mammalian brain tissue , 2011, Analytical and bioanalytical chemistry.

[22]  Bart De Moor,et al.  Prospective Exploration of Biochemical Tissue Composition via Imaging Mass Spectrometry Guided by Principal Component Analysis , 2006, Pacific Symposium on Biocomputing.

[23]  Minh N. H. Nguyen,et al.  Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice , 2003, Science.

[24]  Hanno Langen,et al.  Biomarker Discovery by Imaging Mass Spectrometry , 2006, Molecular & Cellular Proteomics.

[25]  Jonas Bergquist,et al.  Imaging Mass Spectrometry Reveals Elevated Nigral Levels of Dynorphin Neuropeptides in L-DOPA-Induced Dyskinesia in Rat Model of Parkinson's Disease , 2011, PloS one.

[26]  M. Mann,et al.  Electrospray ionization for mass spectrometry of large biomolecules. , 1989, Science.

[27]  J. Bergquist,et al.  Focused proteomics in post-mortem human spinal cord. , 2006, Journal of proteome research.

[28]  E. Melamed,et al.  Spinal Cord mRNA Profile in Patients with ALS: Comparison with Transgenic Mice Expressing the Human SOD-1 Mutant , 2009, Journal of Molecular Neuroscience.

[29]  Vanathi Gopalakrishnan,et al.  Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis , 2005, Journal of neurochemistry.

[30]  A. Kalache,et al.  Active ageing: a policy framework. , 2003, Advances in gerontology = Uspekhi gerontologii.

[31]  Richard M Caprioli,et al.  Molecular imaging of proteins in tissues by mass spectrometry , 2008, Proceedings of the National Academy of Sciences.

[32]  R. Aebersold,et al.  Mass Spectrometry and Protein Analysis , 2006, Science.

[33]  Richard A Yost,et al.  Imaging of lipids in spinal cord using intermediate pressure matrix-assisted laser desorption-linear ion trap/Orbitrap MS. , 2009, Analytical chemistry.

[34]  J. Haines,et al.  Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia , 2011, Nature.

[35]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[36]  S. Rauser,et al.  Normalization in MALDI-TOF imaging datasets of proteins: practical considerations , 2011, Analytical and bioanalytical chemistry.

[37]  Richard M Caprioli,et al.  Molecular analysis of tumor margins by MALDI mass spectrometry in renal carcinoma. , 2010, Journal of proteome research.

[38]  Richard M Caprioli,et al.  Molecular profiling of experimental Parkinson's disease: direct analysis of peptides and proteins on brain tissue sections by MALDI mass spectrometry. , 2004, Journal of proteome research.

[39]  Richard M Caprioli,et al.  Automated acoustic matrix deposition for MALDI sample preparation. , 2006, Analytical chemistry.

[40]  D. Thurman,et al.  How common are the “common” neurologic disorders? , 2007, Neurology.

[41]  Y. Itoyama,et al.  NEDL1, a Novel Ubiquitin-protein Isopeptide Ligase for Dishevelled-1, Targets Mutant Superoxide Dismutase-1* , 2004, Journal of Biological Chemistry.

[42]  Yan Liu,et al.  Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. , 2006, Journal of Alzheimer's disease : JAD.

[43]  Jacqueline Cristini,et al.  misdiagnosis and missed diagnoses in patients with ALS , 2006, JAAPA : official journal of the American Academy of Physician Assistants.

[44]  Richard M Caprioli,et al.  Early Changes in Protein Expression Detected by Mass Spectrometry Predict Tumor Response to Molecular Therapeutics , 2004, Cancer Research.

[45]  M. Stoeckli,et al.  Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues , 2001, Nature Medicine.

[46]  Tyler A. Zimmerman,et al.  The modified-bead stretched sample method: development and application to MALDI-MS imaging of protein localization in the spinal cord. , 2011, Chemical science.

[47]  C. Ross,et al.  Protein aggregation and neurodegenerative disease , 2004, Nature Medicine.

[48]  T. Iwaki,et al.  Involvement of cathepsin B in the motor neuron degeneration of amyotrophic lateral sclerosis , 2003, Acta Neuropathologica.

[49]  R. Cooks,et al.  Mapping lipid alterations in traumatically injured rat spinal cord by desorption electrospray ionization imaging mass spectrometry. , 2011, Analytical chemistry.

[50]  Enikö Kövari,et al.  Proteomics in human Parkinson's disease research. , 2009, Journal of proteomics.

[51]  J. Sweedler,et al.  SIMS and MALDI MS imaging of the spinal cord , 2008, Proteomics.

[52]  R. Caprioli,et al.  Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. , 1997, Analytical chemistry.